Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No.82002413)
Key Lab System Project of Guangdong Science and Technology Department, Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (No. 2017B030314120)
Guangdong Provincial People's Hospital Scientific Research Funds for Leading Medical Talents in Guangdong Province (Grant No. KJ012019426)
- License Information
-
More Information
Article History
Accepted: 22 June 2022
First Online: 25 July 2022
Declarations
:
: Yi-Long Wu declares speaker fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hengrui, MSD, Pfizer, Roche, and Sanofi; consulting and advisory services for AstraZeneca, Boehringer Ingelheim, MSD, Roche. Wen-Zhao Zhong declares speaker fees from AstraZeneca and Roche. Si-Yang Liu and Si-Yang Maggie Liu declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
